16 / 30
Nanobiotechnology 2018
Page 56
Nano Research & Applications
ISSN: 2471-9838
E u r o S c i C o n C o n f e r e n c e o n
Nanotech & Nanobiotechnology
J u l y 1 2 - 1 3 , 2 0 1 8
P a r i s , F r a n c e
N
anotechnology is attracting great attention worldwide in biomedicine. Targeted therapy based on drug nanocarrier systems
enhances the treatment of tumours and enables the development of targeted drug delivery systems. In recent years,
theranostics are emerging as the next generation of multifunctional nanomedicine to improve the therapeutic outcome of
cancer therapy. Polymeric nanoparticles with targeting moieties containing magnetic nanoparticles as theranostic agents have
considerable potential for the treatment of cancer. The use of directed enzyme prodrug therapy (DEPT) has been investigated
as a means to improve the tumour selectivity of therapeutics. Magnetic DEPT involves coupling the bioactive prodrug-activating
enzyme to magnetic nanoparticles that are then selectively delivered to the tumour by applying an external magnetic feld. Gene
therapy is an attractive method for meeting the needs for curing brain disorders, such as Alzheimer’s disease and Parkinson’s
disease. On the other hand, due to the fact that hepatocellular carcinoma (HCC) is resistant to standard chemotherapeutic agents,
gene therapy appears to be a more effective cure for HCC patients. Ultrasound-mediated drug delivery is a novel technique
for enhancing the penetration of drugs into diseased tissue beds noninvasively. This technique is broadly appealing, given the
potential of ultrasound to control drug delivery spatially and temporally in a non-invasive manner.
drhusseinammar@hotmail.comRecent applications of nanotechnology in
advanced drug delivery systems
Hussein O Ammar
Future University, Egypt
Nano Res Appl 2018, Volume 4
DOI: 10.21767/2471-9838-C2-012